Supriya Lifescience Board Meeting on May 27, 2026 to Consider Results

Supriya Lifescience Ltd has scheduled a Board of Directors meeting on May 27, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The board will also consider recommending a dividend, if any, on the equity shares of the company for the financial year ended March 31, 2026. The trading window for dealing in the company's securities is closed from April 1, 2026, until 48 hours after the declaration of the audited financial results.